Table 2.
Gene | Whole Name | Chromosome and Location | Variant(s) (rs ID) | Risk Allele | Mutation | Highlighted Associated Function | (Possible) Implication in CVD Etiology/Pathogenesis | References |
---|---|---|---|---|---|---|---|---|
KCNH8 | Potassium voltage-gated channel subfamily H member 8 | chr3:19293203 (3p24.3) | rs727139 | A > G | - | Smooth muscle contraction | Venous dilation and VV formation | [237] |
EFEMP1 | EGF containing fibulin extracellular matrix protein 1 | chr2:55868859 | rs17278665 | C > G | - | Cell adhesion and migration | Remodeling of ECM components and changes in vessel elasticity by altering the expression of MMPs and TIMPs | [238] |
MMP-9 | Matrix Metallopeptidase 9 | chr20q11.2-q13.1 | - | - | ✓ | ECM degradation | Collagen type I degradation entailing stiffness of vein | [239] |
TIMP-2 | Tissue inhibitor of metalloproteinases 2 | chr17q25.3. | - | - | ✓ | Inhibition of MMPs | Lower expression implies higher collagen degradation by MMPs | [239] |
CASZ1 | Castor zinc finger 1 | chr1:10765520 Intron 1 | rs11121615 | C > T | - | Transcription factor for EGFLD7 | Angiogenesis stimulation and aberrant vascular assembly | [241] |
PIEZO1 | Piezo type mechanosensitive ion channel component 1 | chr16:88769137 (16q24.3) | rs2911463 | G > A/G > C/G > T | ✓ | Shear stress sensing by Ca2+ | Impaired function implies aberrant vascular structure, ECs reorganization and edema | [242,243,244,245] |
PPP3R1 | Protein phosphatase 3 regulatory subunit B, alpha | chr 2:68262089 (2p14) Intergenic |
rs2861819 | G > A/G > C | - | Ca2+ sensitivity | Abnormal vascular integrity | [43] |
EBF1 | Early B Cell Factor Transcription Factor 1 | chr5:158803005 | rs11135046 | G > A/G > T | - | Adhesion and migration in early B lymphopoiesis | Possible epigenetic reprogramming and B cells activation | [247,248] |
GATA2 | GATA Binding Protein 2 | chr3:128578726 | rs9880192 | G > A/G > C | - | Lymphatic vessel valve development | Impaired function implies lymphedema | [240,249] |
NFATC2 | Nuclear Factor of Activated T cells 2 | chr20:51541298 chr20:51538108 |
rs3787184 and rs12625547 |
A > G T > G |
- | Induces immune response or inflammation in vascular remodeling | Not well understood; Acting in consonance with FOXC2 and GJC2. | [248,250] |
FOXC2 | Fork-head box protein C2 | 16q24 | - | - | ✓ | Critical product in developmental processes | Inactivation implies abnormal shear stress sensing and valve incompetence | [251,252] |
GJC2 | Gap junction gamma-2 | 1q41-q42 | - | - | ✓ | Implicated in the gap junctions between cells | Cell-cell junction defects and valve incompetence | [251] |
STIM2 | Stromal interaction molecule 2 | 4:26857601-27025381 (4p15.2) Intergenic variant Mapped gene(s): STIM2, TBC1D19 |
rs28558138 | G > C | - | Controls Ca2+ concentration in cytosol | Higher Ca2+ deposition | [250,253] |
HFE | Homeostatic iron regulator | chr6:26090951 chr6:26267527 |
rs1799945 and rs7773004 |
C > G C > T A > C/A > G/A > T |
✓ | Regulates hepcidin expression, involved in iron storage | Iron overload implies endothelial dysfunction. Moreover, activation of MMPs and inhibition of TIMPs, deposits of iron, RBCs extravasation | [254,255,256] |
SOX9 | SRY-Box Transcription Factor 9 | 17:72032304 17q24.3 |
rs2241173 | A > C A > G |
- | ECM remodeling | Influenced by TGF-β1may involve higher Ca2+ deposition | [24,257,258] |
COL2A1 | Collagen type II alpha 1 chain | 12:47793818 (12q13.11) |
rs73107980 | C > G C > T | - | Coding collagen type II alpha 1 | Abnormal modelling of ECM | [239] |
COL1A2 | Collagen type I alpha 2 chain | chr7:94431047-94431048 | rs3917 | (indels) | - | Coding collagen type I alpha 2 | Collagen dysregulation, higher susceptibility to CVI | [259] |
THBD | Thrombomodulin | 20p11.21 | - | - | ✓ | Related with thromboembolic diseases | Prothrombotic markers | [43] |
MTHFR | Methylenetetrahydrofolate reductase | 1p36.22 | - | - | ✓ | Related with thromboembolic diseases | Prothrombotic markers | [43] |